CASI

Casi Pharmaceuticals, Inc. · HEALTHCARE

No insider bought or sold Casi Pharmaceuticals, Inc. in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow CASI

CASI over the last year

No insider buys filed in this year

CASI after insider buys

3 months after each buy, from the first price a copier could get.

−53.1%Average

−52.4 ptsVs S&P 500

0 of 4Higher

4 buys since 2016 with 3 months of prices.

Every filing

20 insider filings since 2016, newest first

CASIBuy

James Huang · Director

$230K+18.0%Sep 8

CASIBuy

James Huang · Director

$139K+13.0%Sep 2

CASIBuy

James Huang · Director

$167K+19.0%Aug 26

CASIBuy

James Huang · Director

$779KAug 23

CASIBuy

Wei-Wu He · Chair and CEO

$394K+2.0%Nov 19

CASIBuy

Wei-Wu He · Chair and CEO

$614K+3.0%Aug 20

CASIBuy

Wei-Wu He · Chair and CEO

$6.2M+24.0%Mar 30

CASIBuy

Wei-Wu He · Chair and CEO

$488K+2.0%Nov 24

CASIBuy

Wei-Wu He · Chair, CEO and 10% owner

$194K+1.0%May 21

CASIBuy

Wei-Wu He · Chair, CEO and 10% owner

$867K+5.0%May 19

CASIBuy

Wei-Wu He · Chair, CEO and 10% owner

$1.1M+7.0%Mar 27

CASIBuy

Wei-Wu He · Chair, CEO and 10% owner

$1.5M+15.0%Mar 19

CASIBuy

Wei-Wu He · CEO and 10% owner

$507K+3.0%Aug 15

CASIBuy

Idg-Accel China Growth Fund III L.P. · 10% owner

$9.8M+46.0%Mar 23

CASIBuy

Wei-Wu He · Director and 10% owner

Wei-Wu He · Director

Wei-Wu He · Director

Wei-Wu He · Director

Wei-Wu He · Director

Idg-Accel China Growth Fund III L.P. · 10% owner

$2.5M+24.0%Jan 27

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.